Resource Filter: Checkpoint Inhibitors
Spatial predictors of response to immunotherapy inmicrosatellite stable metastatic colorectal cancer
Date
Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence
Date
Profiling the tumor microenvironment through same-section fully automated spatial multiomics
Date
Immune Landscape of Adenoid Cystic Carcinoma using Multiplex Immunofluorescence and Digital Pathology
Date
Development and optimization of a broad hyperplex immunofuorescence assay for tumor immune microenvironment characterization
Date
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade
Date
Studying the immune status of the tumor microenvironment with automated hyperplex immunofluorescence
Date
Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients
Date
Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
Date
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients
Date